Author

Karin Černá

Institutions: Charles University, Iscare I.V.F

Observed institutions: Charles University, Iscare I.V.F

ORCID: 0000-0002-0562-6497

Observed ORCID: 0000-0002-0562-6497

OpenAlex ID: A5058669752

Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab

2024 · Julia Husman, Karin Černá, et al. · International Journal of Colorectal Disease · 10

Subcutaneous infliximab in the treatment of refractory Crohn‘s disease patients – a pilot study of drug immunogenicity

2023 · Karin Černá, Dana Ďuricová, et al. · Gastroenterologie a hepatologie · 1

Switch from biosimilar infliximab CT-P13 to biosimilar infliximab SB-2 in the long-term maintenance therapy in IBD patients – prospective observational study

2023 · Milan Lukáš, Veronika Hrubá, et al. · Gastroenterologie a hepatologie · 1

Roundtable: Subcutaneous infl iximab in the treatment of IBD and therapeutic monitoring of drug levels in practice

2023 · Karin Černá · Gastroenterologie a hepatologie

Two years of the COVID-19 pandemic in the population of Czech patients with inflammatory bowel disease treated with biological therapy – experience of the tertiary IBD center

2023 · Karin Černá, Milan Lukáš · Gastroenterologie a hepatologie

Point-of-care method for measuring infliximab and adalimumab trough levels in inflammatory bowel disease patients on biologic therapy

2022 · Kristýna Kaštylová, Karin Černá, et al. · Gastroenterologie a hepatologie

The association between low number of T regulatory cells, glycoprotein A repetitions predominant (GARP) expression, and short cervical length in preterm labour – results of a pilot study

2022 · Hana Hrbáčková, Michal Koucký, et al. · Journal of Obstetrics and Gynecological Investigations

Subjektivní hodnocení důsledků užívání marihuany

2014 · Karin Černá

Hudební život na Liberecku očima violoncellistky

2014 · Karin Černá

Works count: 9

Citation count: 12

H-index: 1

I10-index: 1